MEREO BIOPHARMA GROUP PLC (MREO) Free cash flow 2022–2025
MEREO BIOPHARMA GROUP PLC (MREO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$31.0MFY2025 · since FY2022: -$48.8M → -$31.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$31.0M | +5.6% |
| FY2024 | -$32.8M | -55.4% |
| FY2023 | -$21.1M | +56.7% |
| FY2022 | -$48.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice